Global Spine Biologics Market is expected to reach USD 2.7 billion by 2022, growing at a CAGR of 4.4% during the forecast period of 2016 to 2022.
Global Spine Biologics Market are segmented based on product type, end-user and geography.
On the basis of product type the spine biologics market is segmented into bone grafts; bone graft substitutes; platelet-rich plasma (PRP) and bone marrow aspirate therapy among others.
For Sample Report: Global Spine Biologics Market – Trends and Forecast to 2022
Based on surgery type, the market is segmented into Anterior Cervical Discectomy and Fusion (ACDF); Transforamenal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF) among others.
Based on end-users the market is segmented into Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others.
Based on geography the market is segmented into geographical regions such as North America, Europe, South America, Asia-Pacific, and Rest of the World (RoW). The report includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific.
To read more about the scope and findings of this report visit: Global Spine Biologics Market is poised to grow at 4.3% from 2016 to 2022
On the basis of application the market is segmented into orthopedic, ENT, neurosurgery dental and others.
Based on end-users the Surgical Navigation Systems and Software market is segmented into hospitals and ambulatory surgical centers.
Based on geography the Surgical Navigation Systems and Software market is segmented into North & South America, Europe, Asia-Pacific and, Middle East & Africa. The report of this market shares countries such as U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among other companies.
KEY PLAYERS OPERATING IN GLOBAL SPINE BIOLOGICS MARKET:
- Arthrex, Inc.
- Cesca Therapeutics, Inc.
- DepuySynthes, Inc.
- DMP Spine
- Exactech, Inc.
- K2m, Inc.
- Lattice Biologics
- Medtronic
- Nuo Therapeutics, Inc.
- Nutech
- Nuvasive, Inc.
- Orthofix Holdings, Inc.
- Regen Lab Sa
- RTI Surgical, Inc.
- Stryker Corporation
- Wright Medical Technology, Inc.
- X-Spine Systems, Inc.
- Zimmer Holdings, Inc.
To Browse Full Report and Pricing: Global Spine Biologics Market – Trends and Forecast to 2022
Table of Content:
1. INTRODUCTION
1.1. Overview of the spine biologics Market
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. Currency and pricing
1.2.2. Limitation
1.2.3. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Key Takeaways
2.2. ARRIVING AT THE global spine biologics market SIZE
2.2.1. Market crackdown approach
2.2.2. Company revenue and market share analysis
2.2.3. Data triangulation
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCEs
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCEs
2.2.6. Porter’s five forces matrix
2.4. GLOBAL spine biologics market: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. global spine biologics Market: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. dRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. Key market trends and upcoming technologies
5. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. BONE GROWTH SUBSTITUTES
5.2.1. DEMINERALIZED BONE MATRIX (DBM)
5.2.2. BONE MORPHOGENETIC PROTEINS (BMP)
5.2.3. Synthetic Bone Grafts
5.3. BONE ALLOGRAFTS
5.4. PLATELET RICH PLASMA (PRP)
5.5. BONE MARROW ASPIRATE CONCENTRATE (BMAC)
6. SPINE BIOLOGICS MARKET, BY SURGERY TYPE
6.1. OVERVIEW
6.2. ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF)
6.3. TRANSFORAMENAL LUMBAR INTERBODY FUSION (TLIF)
6.4. ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
6.5. LATERAL LUMBAR INTERBODY FUSION (LLIF)
6.6. OTHERS
7. SPINE BIOLOGICS MARKET, BY END USER
7.1. Overview
7.2. HOSPITALS
7.3. SPINAL SURGERY CENTERS
7.4. ORTHOPEDIC CLINICS
7.5. OTHERS
8… SPINE BIOLOGICS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE SPINE BIOLOGICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.1.1. U.S.
8.1.1.2. CANADA
8.1.1.3. MEXICO
8.1.2. EUROPE
8.1.2.1. GERMANY
8.1.2.2. FRANCE
8.1.2.3. U.K.
8.1.2.4. ITALY
8.1.2.5. SPAIN
8.1.2.6. RUSSIA
8.1.2.7. TURKEY
8.1.2.8. BELGIUM
8.1.2.9. NETHERLANDS
8.1.2.10. SWITZERLAND
8.1.2.11. REST OF EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.3.1. JAPAN
8.1.3.2. CHINA
8.1.3.3. SOUTH KOREA
8.1.3.4. INDIA
8.1.3.5. AUSTRALIA
8.1.3.6. SINGAPORE
8.1.3.7. THAILAND
8.1.3.8. MALAYSIA
8.1.3.9. INDONESIA
8.1.3.10. PHILIPPINES
8.1.3.11. REST OF APAC
8.1.4. LATIN AMERICA
8.1.4.1. BRAZIL
8.1.4.2. REST OF LATIN AMERICA
8.1.5. MIDDLE EAST AND AFRICA
8.1.5.1. SOUTH AFRICA
8.1.5.2. REST OF MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9… SPINE BIOLOGICS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.2. u.s. SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.4. APAC SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.5. SOUTH AMERICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.6. MIDDLE EAST AND AFRICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
9.7. MERGERS & ACQUISITIONS
9.8. NEW PRODUCT DEVELOPMENT & APPROVALS
9.9. EXPANSIONS
9.10. REGULATORY CHANGES
9.11. PARTNERSHIP AND OTHER STRATEGIC developments
10. SPINE BIOLOGICS MARKET, COMPANY PROFILES
10.1 APPLIED BIOLOGICS
10.1.1 OVERVIEW
10.1.2 SWOT ANALYSIS
10.1.3 PRODUCT PORTFOLIO
10.1.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.2 ARTHREX, INC.
10.2.1 OVERVIEW
10.2.2 SWOT ANALYSIS
10.2.3 PRODUCT PORTFOLIO
10.2.4 REVENUE ANALYSIS
10.2.5 ANALYSTS VIEW
10.3 CESCA THERAPEUTICS
10.3.1 OVERVIEW
10.3.2 SWOT ANALYSIS
10.3.3 PRODUCT PORTFOLIO
10.3.4 REVENUE ANALYSIS
10.3.5 ANALYST VIEW
10.4 DEPUY SYNTHES
10.4.1 OVERVIEW
10.4.2 SWOT ANALYSIS
10.4.3 PRODUCT PORTFOLIO
10.4.4 REVENUE ANALYSIS
10.4.5 ANALYSTS VIEW
10.5 DMP SPINE
10.5.1 OVERVIEW
10.5.2 SWOT ANALYSIS
10.5.3 PRODUCT PORTFOLIO
10.5.4 REVENUE ANALYSIS
10.5.5 ANALYSTS VIEW
10.6 DR. PRP AMERICA LLC.
10.6.1 OVERVIEW
10.6.2 SWOT ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 REVENUE ANALYSIS
10.6.5 ANALYSTS VIEW
10.7 EXACTECH, INC.
10.7.1 OVERVIEW
10.7.2 SWOT ANALYSIS
10.7.3 PRODUCT PORTFOLIO
10.7.4 REVENUE ANALYSIS
10.7.5 ANALYSTS VIEW
10.8 K2M, INC.
10.8.1 OVERVIEW
10.8.2 SWOT ANALYSIS
10.8.3 PRODUCT PORTFOLIO
10.8.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.9 LATTICE BIOLOGICS
10.9.1 OVERVIEW
10.9.2 SWOT ANALYSIS
10.9.3 PRODUCT PORTFOLIO
10.9.4 REVENUE ANALYSIS
10.9.5 ANALYSTS VIEW
10.10 MEDTRONIC
10.10.1 OVERVIEW
10.10.2 SWOT ANALYSIS
10.10.3 PRODUCT PORTFOLIO
10.10.4 REVENUE ANALYSIS
10.10.5 ANALYSTS VIEW
10.11 NUVASIVE, INC.
10.11.1 OVERVIEW
10.11.2 SWOT ANALYSIS
10.11.3 PRODUCT PORTFOLIO
10.11.4 REVENUE ANALYSIS
10.11.5 ANALYSTS VIEW
10.12 ORTHOFIX HOLDINGS, INC.
10.12.1 OVERVIEW
10.12.2 SWOT ANALYSIS
10.12.3 PRODUCT PORTFOLIO
10.12.4 REVENUE ANALYSIS
10.12.5 ANALYSTS VIEW
10.13 REGENLAB S.A.
10.13.1 OVERVIEW
10.13.2 SWOT ANALYSIS
10.13.3 PRODUCT PORTFOLIO
10.13.4 REVENUE ANALYSIS
10.13.5 ANALYSTS VIEW
10.14 RTI SURGICAL
10.14.1 OVERVIEW
10.14.2 SWOT ANALYSIS
10.14.3 PRODUCT PORTFOLIO
10.14.4 REVENUE ANALYSIS
10.14.5 ANALYSTS VIEW
10.15 STRYKER CORPORATION
10.15.1 OVERVIEW
10.15.2 SWOT ANALYSIS
10.15.3 PRODUCT PORTFOLIO
10.15.4 REVENUE ANALYSIS
10.15.5 ANALYSTS VIEW
10.16 WRIGHT MEDICAL
10.16.1 OVERVIEW
10.16.2 SWOT ANALYSIS
10.16.3 PRODUCT PORTFOLIO
10.16.4 REVENUE ANALYSIS
10.16.5 ANALYSTS VIEW
10.17 X-SPINE SYSTEMS
10.17.1 OVERVIEW
10.17.2 SWOT ANALYSIS
10.17.3 PRODUCT PORTFOLIO
10.17.4 REVENUE ANALYSIS
10.17.5 ANALYSTS VIEW
10.18 ZIMMER BIOMET
10.18.1 OVERVIEW
10.18.2 SWOT ANALYSIS
10.18.3 PRODUCT PORTFOLIO
10.18.4 REVENUE ANALYSIS
10.18.5 ANALYSTS VIEW
11. APPENDIX
12. ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Related Reports:
Global Hip Replacement Implants Market – Trends and Forecast to 2022
By Product Type (Cemented Total Hip Implant, Cement Free Total Hip Implant, Partial Femoral Head Implant, Hip Resurfacing, Revision Hip Implants), By End-Users (Orthopedic Clinics, Hospitals, Surgery Centres), By Surgery Numbers (Total Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, Hip Resurfacing), By Geography ((North America By Country), (Europe By Country), (APAC By Country), (MEA By Country), (South America By Country)) – Trends and Forecast to 2022
Asia Pacific Orthopedic Braces and Supports Market – Trends and Forecast to 2022
By Product (Knee Braces & supports, Foot & Ankle Braces and Supports, Spinal Orthoses, Upper Extremity Braces and Supports, Leg Walkers), By End-User (Orthopedic Clinics and Hospitals), By Country (Japan, China, South Korea, India, Singapore, Australia, Rest of APAC) – Trends and Forecast to 2022
Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Sales@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-spine-biologics-market/